Search by Drug Name or NDC
NDC 72893-0002-01 Beleodaq 500 mg/10mL Details
Beleodaq 500 mg/10mL
Beleodaq is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acrotech Biopharma Inc. The primary component is BELINOSTAT.
MedlinePlus Drug Summary
Belinostat is used to treat peripheral T-cell lymphoma (PTCL; a form of cancer that begins in a certain type of cells in the immune system) that has not improved or that has come back after treatment with other medications. Belinostat is in a class of medications called histone deacetylase inhibitors. It works by killing cancer cells.
Related Packages: 72893-0002-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Belinostat Injection
Product Information
NDC | 72893-0002 |
---|---|
Product ID | 72893-002_33fb62b0-3206-4132-87c7-d348aa5ef770 |
Associated GPIs | 21531520002120 |
GCN Sequence Number | 072560 |
GCN Sequence Number Description | belinostat VIAL 500 MG INTRAVEN |
HIC3 | V3A |
HIC3 Description | ANTINEOPLAST,HISTONE DEACETYLASE (HDAC) INHIBITORS |
GCN | 36826 |
HICL Sequence Number | 041264 |
HICL Sequence Number Description | BELINOSTAT |
Brand/Generic | Brand |
Proprietary Name | Beleodaq |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Belinostat |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 500 |
Active Ingredient Units | mg/10mL |
Substance Name | BELINOSTAT |
Labeler Name | Acrotech Biopharma Inc |
Pharmaceutical Class | Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA206256 |
Listing Certified Through | 2024-12-31 |
Package
NDC 72893-0002-01 (72893000201)
NDC Package Code | 72893-002-01 |
---|---|
Billing NDC | 72893000201 |
Package | 1 VIAL in 1 CARTON (72893-002-01) / 10 mL in 1 VIAL |
Marketing Start Date | 2014-07-21 |
NDC Exclude Flag | N |
Pricing Information | N/A |